Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Biocon Ltd - 532523 - Corrigendum To Our Press Release Titled 'Biocon Biologics And Viatris Announce Insulin Glargine (Insulin Glargine-Yfgn) Injection Will Be Offered Through The Walgreens Prescription Savings Club.'

 With reference to our recent intimation titled 'Biocon Biologics and Viatris Announce Insulin Glargine (insulin glargine-yfgn) Injection Will Be Offered Through the Walgreens Prescription Savings Club', we hereby request you to read the word 'Press Release' as 'Company Statement'.
19-11-2021
Bigul

Biocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

 Biocon Biologics and Viatris Announce Insulin Glargine (insulin glargineyfgn) Injection Will Be Offered Through the Walgreens Prescription Savings Club.
19-11-2021
Bigul

BIOCON LTD. - 532523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

 Biocon Biologics and Viatris Announce Insulin Glargine (insulin glargineyfgn) Injection Will Be Offered Through the Walgreens Prescription Savings Club.
19-11-2021
Bigul

BIOCON LTD. - 532523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Investor Meeting
19-11-2021
Bigul

Biocon Ltd - 532523 - Submission Of Amended Biocon India Limited Employees Welfare Trust Deed.

 Pursuant to Regulation 3(3) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021, we would like to inform you that the Biocon India Limited Employees Welfare Trust Deed has been modified to the extent of addition of any scheme promulgated under 'Biocon Welfare Scheme'. Accordingly, we are enclosing herewith a copy of the amended Biocon India Limited Employees Welfare Trust Deed.
18-11-2021
Bigul

Biocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Investor Meeting
18-11-2021
Bigul

Biocon Ltd - 532523 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Arohi Asset Management Pte Ltd
17-11-2021
Bigul

Biocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Investor Meeting
17-11-2021
Bigul

Biocon launches inter-changeable biosimilar insulin in US

 Biocon Biologics Ltd, a subsidiary of Biocon Ltd and Viatris Inc, has announced the US launch of interchangeable biosimilars Semglee (insulin glargine
16-11-2021
Bigul

BIOCON LTD. - 532523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

 Biocon Biologics and Viatris Announce Launch of Interchangeable SEMGLEE(r) (insulin glargine-yfgn) Injection and Insulin Glargine (insulin glargine-yfgn) Injection.
16-11-2021
Next Page
Close

Let's Open Free Demat Account